HomeALSE • OTCMKTS
add
Alseres Pharmaceuticals, Inc.
Previous close
$0.010
Day range
$0.0050 - $0.0050
Year range
$0.0050 - $0.010
Market cap
153.18K USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2013info | Y/Y change |
|---|---|---|
Revenue | 473.73K | — |
Operating expense | 1.42M | — |
Net income | -941.53K | — |
Net profit margin | -198.75 | — |
Earnings per share | — | — |
EBITDA | -968.56K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2013info | Y/Y change |
|---|---|---|
Cash and short-term investments | 310.61K | — |
Total assets | 385.47K | — |
Total liabilities | 10.65M | — |
Total equity | -10.27M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -89.71% | — |
Return on capital | 5.62% | — |
Cash Flow
Net change in cash
| (USD) | 2013info | Y/Y change |
|---|---|---|
Net income | -941.53K | — |
Cash from operations | -1.69M | — |
Cash from investing | 884.36K | — |
Cash from financing | 900.00K | — |
Net change in cash | 97.43K | — |
Free cash flow | -3.04M | — |
About
Founded
1972
Headquarters
Website
Employees
3
